Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.

Mr. Xiaofeng  Yu

Deputy GM & Secretary of the Board

Mr. Shiying  Wang

Deputy General Manager

Mr. Zhong  Yao

Mr. Yixiang  Ai

Ms. Rui  Wang

Mr. Jianlin  Yuan

Mr. Xuguang  Wang

Chief Financial Officer

Ms. Haiyan  Li

Mr. Jianming  Li

GM & Non-Independent Director

Liang  Hong

Marketing Director

名称	市场容量
China Medical System Holdings Limited	0M
TILT Holdings Inc.	0M
ZhuZhou QianJin Pharmaceutical Co.,Ltd	0M
Wockhardt Limited	0M
Chong Kun Dang Pharmaceutical Corp.	0.1M
Eris Lifesciences Limited	0M
Shenzhen Kangtai Biological Products Co., Ltd.	0M
Takeda Pharmaceutical Company Limited	0M
Medical Developments International Limited	0M
Alembic Pharmaceuticals Limited	0M
Hanmi Pharm. Co., Ltd.	0.3M

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. 竞争者名单

主要竞争对手